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Abstract
Background: Randomized controlled trials comparing different vasectomy occlusion techniques
are lacking. Thus, this multicenter randomized trial was conducted to compare the probability of
the success of ligation and excision vasectomy with, versus without, fascial interposition (i.e. placing
a layer of the vas sheath between two cut ends of the vas).
Methods: The trial was conducted between December 1999 and June 2002 with a single planned
interim analysis. Men requesting vasectomies at eight outpatient clinics in seven countries in North
America, Latin America, and Asia were included in the study. The men were randomized to receive
vasectomy with versus without fascial interposition. All surgeons performed the vasectomies using
the no-scalpel approach to the vas. Participants had a semen analysis two weeks after vasectomy
and then every four weeks up to 34 weeks. The primary outcome measure was time to
azoospermia. Additional outcome measures were time to severe oligozoospermia (<100 000
sperm/mL) and vasectomy failure based on semen analyses.
Results: We halted recruitment after the planned interim analysis, when 841 men had been
enrolled. Fascial interposition decreased time to azoospermia (hazard ratio [HR], 1.35; P < 0.0001)
and time to severe oligozoospermia (HR, 1.32; P < 0.0001) and reduced failures based on semen
analysis by about half, from 12.7% (95% confidence interval [CI], 9.7 to 16.3) to 5.9% (95% CI, 3.8
to 8.6) (P < 0.0001). Older men benefited less from fascial interposition than younger men in terms
of the speed of achieving azoospermia. However, the number of vasectomy failures was reduced
to a similar degree in all age groups. Slightly more adverse events occurred in the fascial
interposition group, but the difference was not significant. These failure rates may appear high to
practitioners in countries such as the USA, but they are similar to results from other careful studies
of ligation and excision techniques.
Conclusion: Fascial interposition significantly improves vasectomy success when ligation and
excision is the method of vas occlusion. A limitation of this study is that the correlation between
postvasectomy sperm concentrations and risk of pregnancy is not well quantified.
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Background
Vasectomy failures are considered rare, but the specific
failure rates associated with different vasectomy tech-
niques have not been well documented [1]. Reviews have
cited pregnancy rates after vasectomy of 0–2.2% [2,3].
However, recently reported data based on observational
studies and individual surgeons' reports suggest that fail-
ures are more common than expected following vasecto-
mies performed using ligation and excision [4-7].
The use of fascial interposition (i.e. placing a layer of the
vas sheath between the two cut ends of the vas) may
improve vasectomy success rates. However, no rand-
omized controlled trials have evaluated fascial interposi-
tion, and reports in the literature are conflicting [8,9].
Furthermore, a vasectomy trainer has observed significant
individual variations in how this technique is performed
(personal communication, Ronald Reynolds, Ohio,
March 4, 2003). The Royal College of Obstetricians and
Gynecologists' evidence-based recommendations on
vasectomy note that the evidence in favor of fascial inter-
position is at the lowest level (i.e. expert opinion) [10].
Also, the use of fascial interposition might lead to more
adverse events, since it involves additional tissue manipu-
lation and thus prolongs operating time [11].
Vasectomy success is commonly defined as two consecu-
tive azoospermic specimens, but many laboratories do
not centrifuge specimens for routine clinical testing. Cen-
trifugation of semen samples can detect small numbers of
nonmotile sperm that persist for long periods of time, and
these sperm may have little clinical significance [12,13].
Though not explicitly stated, a World Health Organiza-
tion study of hormonal contraception classified counts of
<100,000 sperm/mL as azoospermic [14], but the gener-
ally accepted definition of azoospermia is the complete
absence of sperm.
Surgeons' experience [15] and guidelines recently pub-
lished by the British Andrology Society [16] suggest that
low concentrations of nonmotile sperm (e.g. <100,000
sperm/mL) are of less concern than higher concentra-
tions. Thus, it may be important to define vasectomy suc-
cess not only by complete absence of sperm but also by
very low sperm concentrations.
Thus we conducted this randomized controlled trial to
compare the probability of success of ligation and exci-
sion of a vas segment with, versus without, fascial interpo-
sition. We considered three outcomes in our analysis: (a)
time to azoospermia, the complete absence of sperm; (b)
time to severe oligospermia, <100,000 sperm/mL; and (c)
vasectomy failure based on the results of semen analyses.
We followed the CONSORT guidelines for reporting clin-
ical trials [17].
Interim results from this study were presented at a plenary
session of the annual meeting of the Association of Repro-
ductive Health Professionals, Washington, DC, USA,
December 14, 2001. A description of the interim analysis
decision process that led to the halting of the study has
been published [18]. A revision of the Royal College of
Obstetricians and Gynaecologists' recommendations [10]
was issued in January, 2004. The new version cites the
published interim results of this study [18] and has
changed the evaluation of the evidence against ligation
and excision alone from the lowest level, "C" based on
expert opinion, to the highest level, "A" based on at least
one randomized controlled trial.
Methods
Study sites and participants
The study was conducted at eight outpatient clinics in
urban locations in Brazil, El Salvador, Mexico (two clin-
ics), Nepal, Panama, Sri Lanka, and the USA, and was con-
ducted in compliance with the Helsinki Declaration.
Family Health International's (FHI's) institutional review
board (IRB) approved the study on August 28, 1998, and
it was also approved by individual IRBs at five of the eight
sites. Because the remaining three sites did not have their
own IRBs, FHI's IRB acted as their primary IRB. All partic-
ipants gave written informed consent.
Men who requested a vasectomy at the study clinics were
screened for eligibility and invited to join the study if they
met all requirements. To be eligible for the study, men
had to (a) satisfy the local clinic's criteria for vasectomy
and (b) be willing to provide a prevasectomy semen sam-
ple and additional semen samples per the planned follow-
up schedule. Men were compensated for the time and
inconvenience of returning for frequent semen analyses.
The compensation amounts were determined separately
for each site. Exclusion criteria included (a) a history of
previous vasectomy or other genital surgery; (b) clinical
evidence of an acute illness including sexually transmitted
infections; (c) history of a bleeding disorder; and (d) a
large varicocele or other scrotal mass.
Participants were randomized to the fascial interposition
or non-fascial interposition group. We used a block rand-
omization method with randomly permuted block sizes
of four, eight, and 12 participants. For allocation conceal-
ment, FHI provided the randomization assignments to
the investigators in sequentially numbered, opaque sealed
envelopes that were opened just prior to the vasectomy
procedure. The surgeons knew the technique being used,
but the laboratory staff who were conducting the semen
analyses were not aware of the group assignments.BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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Vasectomy techniques
Prior to the study, the researchers – all experienced vasec-
tomy surgeons – attended an investigators meeting where
the vasectomy techniques were standardized with the help
of two experienced vasectomy trainers. All surgeons used
the no-scalpel approach to the vas [19]. The vas was then
occluded using two silk sutures, and an approximately 1-
cm segment of vas between the ligatures was excised. For
the fascial interposition technique, a suture was used to
contain the testicular end of the vas inside the fascial
sheath; the prostatic end remained outside (Figure 1).
The investigators completed questionnaires immediately
following each procedure, noting any difficulty experi-
enced with parts of the vasectomy procedure (e.g. isolat-
ing the vas, using the fascial interposition technique). At
two-week follow-up visits and at any unscheduled visits
during the first six weeks, the investigators examined each
patient and completed a questionnaire noting findings
such as sperm granulomas, hematomas, epididymitis, or
wound infection. The diagnosis of sperm granuloma was
based on the clinical finding of swelling at the vasectomy
site. It was not based on histology. We defined wound
infection as a clinical sign of infection (i.e. local inflam-
mation) for which a clinician had prescribed antibiotics.
Semen analysis
We performed standardized semen analyses two weeks
postvasectomy and then every four weeks through 34
weeks, or until success or failure. For men without earlier
vasectomy failure (i.e. those classified as vasectomy suc-
cess or indeterminate), we performed semen analysis
again at 52 weeks.
Laboratory methods were based on procedures recom-
mended by the World Health Organization [20]. Briefly,
participants were asked to produce a semen sample in a
private room at the clinic. Semen was examined within
one hour of collection. An aliquot was examined by
phase-contrast microscopy at high power magnification
(400×) to estimate sperm concentration. Based on the
estimated concentration, dilutions were prepared to
assess exact sperm concentration and motility. The con-
centration and motility of each sample were determined
using a Neubauer hemocytometer. Samples with very low
sperm numbers (<5 sperm per high power field) on the
initial exam were centrifuged for 15 minutes at 600 g and
then assessed for sperm concentration and motility as
described above. Each laboratory conducted periodic
quality-control tests.
Study outcomes
The primary study outcome for vasectomy success was
time to azoospermia, defined as two consecutive
azoospermic specimens taken at least two weeks apart.
Two other study outcomes were (1) time to azoospermia
or to severe oligozoospermia in two consecutive speci-
mens taken at least two weeks apart, and (2) vasectomy
failure based on the results of semen analysis. We defined
severe oligozoospermia as 1 to <100,000 sperm/mL.
Throughout the text and tables, the second outcome (time
to azoospermia or to severe oligozoospermia) is referred
to as severe oligozoospermia.
We defined the date of vasectomy success as the date of
the first of two azoospermic or severely oligospermic
semen samples. Because older men take longer to reach
azoospermia, we analyzed the data by age group in addi-
tion to examining overall effects. In the analyses of time to
success, once a man met the definition of a vasectomy fail-
ure, he was classified as such and was considered as
remaining a failure through 34 weeks, whether or not he
continued clinical follow-up visits.
To define vasectomy failure, we used a criterion for early
failure based on a report by Alderman [21]: the presence
of more than 5 million motile sperm/mL at week 14 or
later. We initially defined late failure as any motile sperm
at 26 weeks or later. After the study began, we amended
this because of the concern that motility could be difficult
to evaluate in semen samples with very low sperm concen-
trations. The amended criterion specified the presence of
more than 100,000 sperm/mL with any sperm motility. If
a participant's semen analyses did not meet the primary
criterion for success (azoospermia) or the criterion for
failure, his outcome was indeterminate.
Partway through the study, the protocol was amended to
gather extended follow-up data (up to 52 weeks) on men
who were classified as vasectomy failures. This amend-
Standardized fascial interposition technique Figure 1
Standardized fascial interposition technique A suture 
is used to position the stump of the prostatic end outside of 
the fascial sheath and the stump of the testicular end inside 
the fascial sheath. Source: EngenderHealth: No-Scalpel Vasec-
tomy: An Illustrated Guide for Surgeons. 3rd edition. New York: 
EngenderHealth; 2003. Reprinted with permission.BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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ment facilitated clinicians' follow-up of men classified as
early failures, to determine whether they would become
azoospermic with longer follow-up. For men who became
clinical successes with longer follow-up, their statuses
were not changed for the life-table analyses of time to
success.
Sample size estimation
We chose a study size of 1200 men, with 150 to be
enrolled at each of the eight sites. We based this sample
size on data showing that the cumulative chance of suc-
cess through 22 weeks is about 82% for vas occlusion
without fascial interposition, when success is defined as
two consecutive azoospermic samples at least two weeks
apart [7]. Assuming that the cumulative chance of success
through 34 weeks of follow-up is 85% when fascial inter-
position is not used, and 90% when fascial interposition
is used, enrolling at least 1156 participants would assure
90% power to detect a difference between the groups,
with a one-sided test and an alpha of 0.05.
Statistical analysis methods
Cox proportional hazards regression was used to estimate
anticipated improvement in the hazard ratio [HR] for suc-
cessful vasectomy for the fascial interposition group ver-
sus the non-fascial interposition group, controlling for age
and for surgeon experience (three surgeon groups based
on prior experience with fascial interposition). A one-
sided test with an alpha of 0.05 was used. We chose to use
a one-sided test because of expert opinion that fascial
interposition might improve vasectomy effectiveness and
was very unlikely to have a negative effect. An age-by-treat-
ment interaction was found in this primary comparison,
so both overall and age-specific HRs were determined to
more adequately explain the impact of fascial interposi-
tion on time to vasectomy success.
Kaplan-Meier product limit estimates, with 95% confi-
dence intervals [CIs], of the probabilities of success at each
scheduled week of follow-up through week 34 were deter-
mined overall, by treatment group and, because of the
age-by-treatment interaction, by treatment group and age
group. Peto's standard error [22] was used to compute the
95% CIs.
The proportions of vasectomy failures in the treatment
groups were estimated and compared using logistic regres-
sion, controlling for age and surgeon experience.
A two-way analysis of variance that controlled for surgeon
experience and participant age was used to compare dura-
tion of surgical procedure. Incidence of any surgical diffi-
culty and of adverse events related to vasectomy were
compared using a Mantel-Haenszel test, stratified by sur-
geon experience. The treatment-by-surgeon experience
interactions for these comparisons were tested using the
Breslow-Day test.
Interim analysis
We conducted a single planned interim analysis after the
first 400 participants had completed 10 weeks of follow
up. The results were reviewed by a data safety monitoring
board (DSMB) composed of three independent and expe-
rienced researchers: a urologist, a statistician, and a clini-
cal epidemiologist. The DSMB reviewed only the primary
study outcome (i.e. time to azoospermia). Though a dif-
ference by age group complicated the DSMB's review of
the results [18], the interim analysis showed a significant
overall effect in favor of fascial interposition at the prede-
fined significance level (P < 0.01). As a result, we halted
recruitment in May 2001, but follow up continued for all
enrolled participants.
Results
Baseline population data and participant disposition
Recruitment began in December 1999. 841 men (419
allocated to the fascial interposition group and 422 to the
non-fascial interposition group) were enrolled and had
vasectomies before recruitment was halted in May 2001;
they constituted the treated population. 826 men
returned for at least one semen analysis; they constituted
the primary analysis population (Figure 2). The baseline
data (Table 1) included all participants who returned for
at least one semen analysis. The final follow-up visits were
completed in June 2002. Unless specified, the efficacy
results presented below are from the primary analysis
population, and the safety results are from the treated
population. 15 men did not return for any semen analyses
and were excluded from the primary analysis population.
24 men were lost to follow up before reaching success,
being declared a failure, or completing 34 weeks of fol-
low-up (Figure 2).
Time to success based on semen analyses
For the primary analysis population, the survival curves
for time to azoospermia and time to severe oligozoosper-
mia showed highly significant differences between the
two groups, in favor of fascial interposition (Figure 3).
The HRs were 1.35 for azoospermia and 1.32 for severe
oligozoospermia (P < 0.0001 for both outcomes).
When time to azoospermia was examined by age group,
younger men benefited the most from fascial interposi-
tion, especially when evaluated 14 weeks postvasectomy
(Table 2). For men under age 30 years, those in the fascial
interposition group were more than twice as likely to
reach azoospermia than were those in the non-fascial
interposition group (HR, 2.3; P < 0.0001). The difference
between groups gradually disappeared with age. By age 40
years and older, men reached azoospermia at about theBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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same rate whether they were in the fascial interposition
group or the non-fascial interposition group (HR, .98; P =
0.54).
When time to severe oligozoospermia was examined by
age group, men younger than 35 years were significantly
more likely to reach oligozoospermia than men of the
same age in the non-fascial interposition group (Table 2).
HRs were 1.7 (P = 0.0003) for men younger than 30 years
and 1.3 (P = 0.03) for men 30 to 34 years old. Men 35
years and older still benefited from fascial interposition,
but differences in time to oligozoospermia between the
fascial interposition and non-fascial interposition groups
were not statistically significant (HR, 1.17 and P = 0.15 for
men 35 to 39 years old; HR, 1.21 and P = 0.11 for men at
least 40 years old).
In summary, the advantage of fascial interposition was
more consistent across age groups when based on time to
oligozoospermia than when based on time to
azoospermia.
With respect to median time to success, men reached
severe oligozoospermia six to eight weeks before they
reached azoospermia. Among men in the fascial interpo-
sition group, the median times to success were four weeks
using the oligozoospermia endpoint and 10 weeks using
the azoospermia endpoint. Among men in the non-fascial
Participant disposition flow chart Figure 2
Participant disposition flow chart
841 Enrolled 
419 Received fascial interposition  422 Did not receive fascial interposition
410 Included in primary analysis population 
343  Vasectomy successes 
24  Vasectomy failures 
12 Received extended follow-up
12 Did not receive extended
     follow-Up 
 29  Indeterminate outcome
14 Lost to follow-up 
9 Did not return for any semen
                 analyses
416 Included in primary analysis population 
 331  Vasectomy successes
 53  Vasectomy failures
24 Received extended follow-up
29 Did not receive extended
     follow-up 
 22  Indeterminate outcome
10 Lost to follow-up 
   6  Did not return for any semen
analyses
399 No  protocol violations/exclusions
11  Protocol violations 
10 Could not complete vasectomy
              as assigned 
  1  M a jor protocol violation
414 No  protocol violations/exclusions
 2  Protocol violations
  1 Could  not complete vasectomy
    as assigned 
1M a jor protocol violationBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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interposition group, the median times to success were six
and 14 weeks, respectively.
Failures based on semen analyses
By the 34-week visit, 77 vasectomy failures occurred: 24
(5.9%) of 410 vasectomies in the fascial interposition
group (confidence interval [CI], 3.8 to 8.6) and 53
(12.7%) of 416 vasectomies in the non-fascial interposi-
tion group (CI, 9.7 to 16.3) (P = 0.0008). While the time-
to-success results showed differences in the benefit of fas-
cial interposition by age group, this was not the case with
failures. All age groups had fewer failures with fascial
interposition than without (Table 3).
Pregnancies and later follow up
Four pregnancies were reported during the study period
(two in each group). Semen analyses performed close to
the dates of conception showed that the semen of all four
men contained motile sperm. The estimated time between
vasectomy and the date of conception ranged from 41 to
91 days. Based on subsequent semen analyses, one case in
each group was a success and one a failure. Three of the
four pregnancies occurred at one center.
Among the 77 men with vasectomy failures, 36 (46.8%)
accepted an offer of extended follow up (12 from the fas-
cial interposition group and 24 from the non-fascial inter-
position group). 10 (27.8%) of these 36 men eventually
became azoospermic or severely oligospermic (three of 12
in the fascial interposition group and seven of 24 in the
non-fascial interposition group), generally between 22
and 42 weeks postvasectomy. At the 52-week visit, persist-
ent sperm were found in 24 men who had been classified
as vasectomy successes or indeterminate. 17 of the 24 had
sperm concentrations of less than 100,000 sperm/mL. Of
the 7 who had higher concentrations, two had been clas-
sified as successes (likely with subsequent late
recanalization): one had concentrations of 100,000
sperm/mL and the other 400,000 sperm/mL. The remain-
ing five had been classified as indeterminate and had con-
centrations ranging from 125,000 to 27 million sperm/
mL. Six of the seven were in the non-fascial interposition
group.
We collected supplementary follow-up data from 46
(59.8%) of the 77 men who had vasectomy failures. 29 of
these men had undergone repeat vasectomies; 15 men
had not had a repeat vasectomy at last contact; and the
wives of two men had undergone postpartum tubal
ligations.
Surgical procedures
Surgery took approximately two to three minutes longer
when it included fascial interposition than when it did
not. Mean surgical times were 14.3 minutes for the fascial
interposition group versus 11.7 minutes for the non-fas-
Table 1: Baseline characteristics
Number (%)
Characteristic With fascial interposition (n = 410) Without fascial interposition (n = 416)
Age group, years
<30 109 (26.6) 85 (20.4)
30 to 34 125 (30.5) 126 (30.3)
35 to 39 95 (23.2) 104 (25.0)
40+ 81(19.8) 101 (24.3)
Marital status
Married 344 (83.9) 363 (87.2)
Partnered 52 (12.7) 49 (11.8)
Not partnered 14 (3.4) 4 (.96)
Number of children
0 20 (4.9) 11 (2.6)
1 22 (5.4) 20 (4.8)
2 210 (51.2) 206 (49.5)
3+ 158 (38.5) 179 (43.0)
BMI > 30
No 369 (90.0) 364 (87.5)
Yes 41 (10.0) 52 (12.5)
Prior condom use
No 213 (52.0) 239 (57.4)
Yes 197 (48.0) 177 (42.5)
BMI: Body mass indexBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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Cumulative event probabilities by treatment group Figure 3
Cumulative event probabilities by treatment group Thin line, no-scalpel vasectomy with fascial interposition. Thick line, 
no-scalpel vasectomy without fascial interposition. 3.A: Time to success as defined by azoospermia. 3.B: Time to success as 
defined by severe oligozoospermia, <100,000 sperm/mL.
A. Azoospermia
B. Severe  oligozoospermiaBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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cial interposition group (P < 0.0001). The median surgical
times were 12 minutes for the fascial interposition group
versus 10 minutes for the non-fascial interposition group.
The range of operating times was 5–60 minutes versus 4–
75 minutes, respectively. Only three sites had cases with
operating times longer than 30 minutes. At one of those
sites, teaching activities contributed to the longer operat-
ing times.
The fascial interposition technique posed some difficulty
for surgeons in 58 (13.8%) of 419 cases. However, sur-
geons in only nine (2.1%) of the 419 cases were unable to
perform the fascial interposition procedure on one or
both vas. Surgical difficulties with other aspects of the
vasectomy procedure were not affected by the use of fas-
cial interposition (data not shown).
Safety results
As indicated by reported analgesic use, postsurgical pain
was mild, brief, and virtually identical in both groups.
Among 820 men with data on postsurgical pain, 528
(64.4%) reported taking no analgesics. 231 (28.2%)
reported analgesic use for one to three days, 47 (5.7%) for
up to one week, and 14 (1.7%) for more than a week.
In the early follow-up period, within six weeks of surgery,
74 (17.7%) of the 419 men in the fascial interposition
group versus 62 (14.7%) of the 422 men in the non-fas-
cial interposition group reported one or more related
adverse events. Although slightly more adverse events
occurred in the fascial interposition group, the difference
was not significant (P = 0.23).
Table 2: Kaplan-Meier product limit estimates of probabilities of success
Age group, years Probability of success (95% CI)
With fascial interposition Without fascial interposition
Azoospermia, 14 weeks
Overall 71% (67, 76) 61% (56, 66)
<30 91% (85, 97) 62% (51, 72)
30 to 34 71% (63, 80) 64% (56, 73)
35 to 39 69% (59, 79) 64% (54, 73)
40+ 48% (37, 59) 53% (44, 63)
Azoospermia, 34 weeks
Overall 86% (82, 91) 83% (78, 87)
<30 95% (90, 99) 80% (71, 90)
30 to 34 85% (77, 93) 81% (74, 86)
35 to 39 89% (81, 97) 88% (81, 95)
40+ 75% (59, 91) 81% (72, 90)
Severe Oligozoospermia, 14 weeks
Overall 91% (88, 94) 82% (78, 86)
<30 94% (89, 99) 77% (68, 87)
30 to 34 89% (83, 95) 82% (75, 89)
35 to 39 91% (85, 97) 84% (76, 91)
40+ 91% (85, 97) 83% (76, 90)
Severe Oligozoospermia, 34 weeks
Overall 94% (92, 97) 87% (84, 91)
<30 95% (90, 99) 86% (80, 96)
30 to 34 92% (87, 97) 87% (81, 93)
35 to 39 96% (91, 100) 89% (82, 96)
40+ 95% (89, 100) 86% (79, 93)
CI: Confidence intervalBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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The two diagnoses responsible for the slight difference in
adverse events between the fascial interposition and the
non-fascial interposition groups were sperm granuloma
in 41 (9.8%) versus 29 (6.9%) of the cases and epididymi-
tis or orchitis in 12 (2.9%) versus six (1.4%) of the cases,
respectively. Three of the eight centers accounted for virtu-
ally all of the reports of sperm granuloma. Common
events that occurred in equal numbers between groups
were scrotal pain or swelling in 22 cases (2.6%) and
hematomas in 12 (1.4%). The hematomas were small (2
cm or less in diameter), and none required drainage.
Infections occurred in four (0.48%) of the cases (two in
each group).
675 (89%) of 757 men classified as vasectomy successes
or indeterminate attended the 12-month follow-up visit.
At that visit, we asked the men if they had had any scrotal
pain within the past three months. 652 (97%) reported
no pain. In the fascial interposition group, nine (2.6%) of
346 reported pain (seven mild and two moderate); in the
non-fascial interposition group, 14 (4.3%) of 326 (11
mild and three moderate). No men reported severe pain.
Three serious adverse events were considered related to
the vasectomy. One man in each treatment group was
hospitalized for epididymo-orchitis (one with onset one
day and one with onset two months postvasectomy); and
a man in the fascial interposition group was hospitalized
with a painful granuloma of the spermatic cord eight
months postvasectomy. Two of the three men were hospi-
talized for only one night. Two other men were hospital-
ized for events involving the genitourinary system:
elective hernia surgeries one month and one year postva-
sectomy. These events were considered unrelated to
vasectomy.
Discussion
To our knowledge, this is the first large randomized con-
trolled trial of a vas occlusion technique. We found that
the use of fascial interposition leads to more rapid
achievement of both azoospermia and oligozoospermia
and reduces vasectomy failures by about half when liga-
tion and excision is used as the method of vas occlusion.
All vasectomies in this study were done using the no-scal-
pel vasectomy approach to the vas, but our findings
should be generalizable to procedures done with the
standard incision approach, as it is unlikely that the
approach to the vas would affect failure rates.
Five participants who had significant sperm concentra-
tions at the 52-week visit had their vasectomies classified
as indeterminant. If these five had been classified as fail-
ures, the benefit shown by fascial interposition would
have been even higher. Thus, the advantage of fascial
interposition clearly outweighs the additional two to
three minutes needed to perform the procedure. Our
results confirm some expert opinion on the value of fas-
cial interposition and that ligation and excision should
not be used alone given the high failure rate [10].
Slightly more adverse events did occur in the fascial inter-
position group than in the non-fascial interposition group
during the six weeks after surgery, but the difference was
not clinically or statistically significant. One could specu-
late that the slightly longer duration of the procedure and
the presence of an additional piece of suture when fascial
interposition is used might have contributed to this non-
significant difference. Serious adverse events were rare in
both groups.
We also found that time to severe oligozoospermia was a
more useful outcome measure than was time to
azoospermia. The analyses based on severe oligozoosper-
mia provided results that were more consistent with the
ultimate outcome of vasectomy success or failure. This
was apparently because of the very slow and inconsistent
achievement of azoospermia among older men who even-
tually achieved success. The slower achievement of
azoospermia in older men was probably related to their
having less frequent ejaculations than younger men (data
not shown).
Table 3: Vasectomy failures based on semen analysis, by treatment and age group
Age group, years Number and percentage of failures (95% CI)
With fascial interposition Without fascial interposition
Overall 24 5.9% (3.8, 8.6) 53 12.7% (9.7, 16.3)
<30 5 4.6% (1.5, 10.4) 12 14.1% (7.5, 23.4)
30 to 34 10 7.9% (3.8, 14.0) 19 15.1% (9.3, 22.5)
35 to 39 6 6.3% (2.3, 13.1) 10 9.6% (4.7, 17.0)
40+ 3 3.6% (0.7, 10.1) 12 11.9% (6.3, 19.8)
CI: Confidence intervalBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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The percentages of men with vasectomy failures based on
semen analyses (5.9% with and 12.7% without fascial
interposition) appear inconsistent with the commonly
quoted pregnancy rates of 1% or less after vasectomy.
However, despite the large amount of published data on
the failure rates of various vasectomy techniques, there are
relatively few detailed semen analysis data from well-
designed studies. Interpreting the published data is diffi-
cult because most data are from retrospective reviews of
individual physicians' experiences; follow-up details and
semen analysis methods vary widely and are often not
carefully described; and various outcome definitions are
used. Prospectively gathered data with frequent semen
analyses are unusual. In fact, a broad range of failure rates
based on semen analysis and pregnancy have been
reported for vasectomy by ligation and excision; including
rates as high as 3–10% [4-7].
Data from Nepal showed a cumulative pregnancy rate of
4.2% at 36 months postvasectomy in a program where
ligation and excision was the most common method of
vas occlusion and where postvasectomy semen analyses
were not available [4]. Data from China have shown
higher pregnancy rates than in Nepal, 9.5% at five years,
but these data are difficult to interpret [5]. In a Canadian
study of clip ligation and excision, using two clips per vas,
careful follow up showed a failure rate of 8.7% based on
semen analyses [6]. Data from a study of ligation and exci-
sion without fascial interposition in Mexico found a fail-
ure rate of 11.5% based on semen analysis through 24
weeks [7], similar to the 12.7% found in this study.
Since extended follow up in our study led to azoospermia
in some men classified as vasectomy failures, and since
women's age and fertility status are independent determi-
nants of pregnancy, pregnancy rates would be lower than
failure rates based on semen analyses. None-the-less,
vasectomy failure and pregnancy rates in high-resource
settings such as the USA [3] are estimated to be much
lower than those cited above. Possible reasons for this dif-
ference include: (a) the availability of routine semen anal-
ysis provides rapid feedback to surgeons so that they can
improve their occlusion techniques – or stop doing vasec-
tomies – if they see too many vasectomy failures among
their clients; (b) semen analysis identifies many vasec-
tomy failures; (c) most surgeons in the USA use cautery
(71%), usually in conjunction with clips or ligation [23];
and (d) men from the USA are generally older – and have
older, less fertile wives – than men from Nepal and China
at the time of vasectomy. Nazerali et al [4] found that
pregnancies decreased with increasing spousal age.
In light of our results, and given the feedback that clini-
cians routinely receive in the USA from laboratory results
and from the medicolegal system, it seems unlikely that
the estimated 18% of surgeons who report using ligation
and excision in the USA [23] currently use the standard-
ized techniques that we studied.
Our results underscore the importance of the details of vas
occlusion techniques for vasectomy success. While surgi-
cal experience is frequently cited as a key determinant of
vasectomy success, our study suggests that the details of
the vas occlusion technique are at least as important.
Goldstein [11] suggests that intraluminal cautery is the
most effective method of vas occlusion, based on the
report by Schmidt [24]. However, data from randomized
controlled trials are lacking.
Our study outcomes were based on semen analysis data
rather than on pregnancy data so that we could minimize
sample size, study duration, and pregnancy risk. Despite
the 77 vasectomy failures identified by semen analyses,
only four pregnancies were reported (two in each group).
The number of pregnancies was probably small because of
the frequent reinforcement of the counselling messages at
the time of the semen analyses: continue using a back-up
contraceptive method until azoospermia is achieved and
– in cases of failure – do not rely on the vasectomy. We are
not currently planning to gather longer-term follow-up
data on the study participants for the possible later occur-
rence of additional pregnancies.
Counselling should always include information on the
possibility of vasectomy failure. However, as shown by
this study, vasectomy failure rates may differ substantially
for different vas occlusion techniques. Where semen anal-
yses are not available, clinicians have often recommended
a waiting period of 20 ejaculations or three months before
a man should rely on his vasectomy for contraception.
Barone et al [7] have shown that three months is a better
criterion than 20 ejaculations when ligation and excision
is used. The results of this study are consistent with that
recommendation (data not shown).
Conclusions
We have shown that the use of fascial interposition in con-
junction with ligation and excision decreases time to
azoospermia, decreases time to severe oligozoospermia,
and reduces vasectomy failure rates by about half when
failures are defined by semen analyses. Vasectomy success
depends on the technique of vas occlusion that is used at
least as much as on the surgical experience of the operator.
Limitations of this study are that: (a) these findings are
not necessarily applicable to vas occlusion by other meth-
ods; and (b) the correlation between postvasectomy
sperm concentrations and risk of pregnancy is not well
quantified.BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/6
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